Can Atorvastatin reduce lipid-induced inflammation in cardiovascular diseases, and how does this benefit patients with chronic atherosclerosis?
Sahil KapoorExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Atorvastatin reduces lipid-induced inflammation in cardiovascular diseases by lowering cholesterol levels, which stabilizes plaques and prevents arterial damage, benefiting patients with chronic atherosclerosis.
Atorvastatin, by lowering LDL cholesterol, mitigates lipid-induced inflammation, helping stabilize atherosclerotic plaques and reducing the risk of cardiovascular events in chronic atherosclerosis sufferers.